Wheeler Benjamin Richard 4

What Happened
Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics (MYGN), was granted 206,186 restricted stock units (RSUs) on March 12, 2026 (reported as an award/acquisition). Following the grant, the company withheld a total of 4,752 shares across March 13–15, 2026 to satisfy tax withholding obligations; the withholding transactions were reported as dispositions at $4.66 per share for an aggregate withholding of about $22,145. The RSUs are time‑based and vest in three equal annual installments beginning on the first anniversary of the grant (per footnote).

Key Details

• Grant date: 2026-03-12 — 206,186 RSUs granted (time-based; vest in 3 equal annual installments) (F1).
• Withheld shares (to cover taxes):
  • 2026-03-13: 586 shares withheld @ $4.66 = $2,731 (F2)
  • 2026-03-14: 1,097 shares withheld @ $4.66 = $5,112 (F2)
  • 2026-03-15: 877 shares withheld @ $4.66 = $4,087 (F2)
  • 2026-03-15: 2,192 shares withheld @ $4.66 = $10,215 (F3)
  • Total withheld: 4,752 shares for ~ $22,145.
• Price basis for withholding: closing price on March 13, 2026 (per footnotes F2/F3).
• Shares owned following the transactions: not specified in the filing.
• Filing date: 2026-03-16 — appears timely (filed within required business-day window).

Context
The primary event is an equity award (RSUs), an acquisition that vests over time rather than an open-market purchase. The subsequent disposals were routine share-withholdings to cover tax liabilities tied to vesting (not open-market sales for cash profit). Such tax-withholding transactions are common and generally considered administrative rather than a direct signal of insider sentiment.